{
    "title": "Endocrine immune-related adverse events: Adrenal, parathyroid, diabetes insipidus, and lipoatrophy.",
    "doc_id": "35382989",
    "writer": "Atkinson M",
    "year": "2022",
    "summary": "These include hypophysitis, thyroid disease, and autoimmune diabetes mellitus, and rarer endocrinopathies such as primary adrenal insufficiency, diabetes insipidus, parathyroid disease, autoimmune polyglandular syndrome, lipodystrophy, and ACTH-depende â€¦",
    "abstract": "Immune checkpoint inhibitors are being prescribed increasingly widely for a range of malignancies. They are effective at treating certain cancers, but also have significant side effects. Evidence suggests that efficacy is greatest in patients who experience one or more immune-related adverse events (irAEs). Common irAEs include skin and hepatic reactions, and a range of immune-related endocrinopathies. These include hypophysitis, thyroid disease, and autoimmune diabetes mellitus, and rarer endocrinopathies such as primary adrenal insufficiency, diabetes insipidus, parathyroid disease, autoimmune polyglandular syndrome, lipodystrophy, and ACTH-dependent Cushing's syndrome. Herein, we review the current literature related to these rarer immunotherapy-induced endocrinopathies.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/35382989/",
    "clean_text": "endocrine immune related adverse events adrenal parathyroid diabetes insipidus and lipoatrophy these include hypophysitis thyroid disease and autoimmune diabetes mellitus and rarer endocrinopathies such as primary adrenal insufficiency diabetes insipidus parathyroid disease autoimmune polyglandular syndrome lipodystrophy and acth depende immune checkpoint inhibitors are being prescribed increasingly widely for a range of malignancies they are effective at treating certain cancers but also have significant side effects evidence suggests that efficacy is greatest in patients who experience one or more immune related adverse events iraes common iraes include skin and hepatic reactions and a range of immune related endocrinopathies these include hypophysitis thyroid disease and autoimmune diabetes mellitus and rarer endocrinopathies such as primary adrenal insufficiency diabetes insipidus parathyroid disease autoimmune polyglandular syndrome lipodystrophy and acth dependent cushing s syndrome herein we review the current literature related to these rarer immunotherapy induced endocrinopathies"
}